Ascending triangle formed after a 5-month correction. Multiple new support confirmation over the past few days.
There is a potential to aim March's high and target a $105 price mark. However, not before we break past our original target exit below.
Despite profit potential might not seem appealing, I still feel that the risk/reward ratio is acceptable. Needless to say that the price will highly be influenced by vaccine-related news, given YUM's industry.
- Target Entry $98.79
- Target Stop Loss $97.67
- Target Exit $102.90
About me
- P/L September +49.18% | August: +232.32% | No Trades without Analysis
- Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss
There is a potential to aim March's high and target a $105 price mark. However, not before we break past our original target exit below.
Despite profit potential might not seem appealing, I still feel that the risk/reward ratio is acceptable. Needless to say that the price will highly be influenced by vaccine-related news, given YUM's industry.
- Target Entry $98.79
- Target Stop Loss $97.67
- Target Exit $102.90
About me
- P/L September +49.18% | August: +232.32% | No Trades without Analysis
- Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss
أغلقت الصفقة: تم الوصول لوقف الخسارة:
-1.34% loss